Blackstone Completes Previously Announced Acquisition of Sphera, Leading Provider of ESG Software, Data, and Consulting Services

NEW YORK and CHICAGO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Sphera today announced that private equity funds managed by Blackstone (NYSE: BX, “Blackstone”) have completed their previously announced acquisition of Sphera, a leading provider of environmental, social and governance (ESG) software, data and consulting services, from Genstar Capital. The transaction, which values the company at $1.4 billion, continues Blackstone’s thematic investment focus on the ESG sector and provides Sphera with capital to help accelerate its growth and product offerings.

Spanning over 80 countries with more than 3,000 customers, Sphera combines its software as a service solution with consulting services, underpinned by proprietary data, to support businesses globally to manage and mitigate ESG risk. This support is delivered through its three product lines: Environment, Health, Safety & Sustainability (EHS&S); Operational Risk Management; and Product Stewardship.

As part of Sphera’s strategic growth efforts, the company is also announcing the appointment of Kimberly Kolb as chief human resources officer (CHRO). As CHRO, Kolb will be responsible for developing and supporting Sphera’s global workforce as the organization continues to grow its footprint worldwide. She brings over 30 years of human resources, consulting and marketing experience from technology, professional service and financial services firms to the position, and held senior leadership roles at Whittman-Hart, CME Group and XR Trading.

Paul Marushka, CEO and president at Sphera, said, “As we enter this new stage, we are excited to be able to partner with Blackstone. Our achievements to date are a result of the dedication, hard work and effort of the team at Sphera. I am proud to collaborate with such a dedicated team as we take Sphera, with Blackstone’s investment and support, to the next level. This partnership with and capital injection by Blackstone will facilitate the next evolution of innovation, cementing our position as leaders and allowing us to push ahead with our vision for ESG software integration with extensive data and world-class consultancy services.”

Eli Nagler, a senior managing director at Blackstone, said: “We are excited to partner with Paul Marushka and his team to build on Sphera’s strong momentum as a trusted leader in the ESG solutions space. We look forward to supporting the company in the next phase of its growth journey as they continue to expand their product offerings and innovate to best serve their global customer base.”

Note to editors

About Sphera
Sphera creates a safer, more sustainable and productive world. We are a leading global provider of Environmental, Social and Governance (ESG) performance and risk management software, data and consulting services with a focus on Environment, Health, Safety & Sustainability (EHS&S), Operational Risk Management and Product Stewardship. Learn more about Sphera at www.sphera.com. Follow Sphera on LinkedIn.

About Blackstone
Blackstone is one of the world’s leading investment firms. We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. We do this by using extraordinary people and flexible capital to help companies solve problems. Our $684 billion in assets under management include investment vehicles focused on private equity, real estate, public debt and equity, life sciences, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. Further information is available at www.blackstone.com. Follow Blackstone on Twitter @Blackstone.

Contact:

Sphera Solutions, Sphera@AspectusGroup.com

Fairmont Hotels & Resorts Unveils New Global Brand Campaign: “Experience The Grandest of Feelings,” Celebrating its Extraordinary Locations, Awe-Inspiring Landscapes and Illustrious Origins

Oscar-winning actress Susan Sarandon stars as the brand’s Global Ambassador

PARIS, Sept. 14, 2021 /PRNewswire/ — Fairmont Hotels & Resorts has debuted a new and unforgettable chapter in its storied 100-year plus history, Experience The Grandest of Feelings, a global brand campaign that pays tribute to the tangible echoes of the luxury brand’s historic origins while also imparting a refreshed vision and stirring images of adventures yet to come. The visionaries who made history in creating Fairmont’s first hotels and those who continue to preserve and protect the abundant natural landscapes wherever Fairmont resides is a key theme throughout the creative of the campaign.  The tradition of thoughtful hospitality amid spectacular scenery around the globe firmly roots the brand in nature and its preservation.

“Travel is truly one of the most unique unifiers and equalizers. The how, why, and where we travel is unimportant: the transcendent act of traveling – no matter how far – opens up the mind to diversity and inclusion that boldly drives society forward,” said Mansi Vagt, Vice President, Fairmont Hotels & Resorts.  “Experience The Grandest of Feelings celebrates just that and captures the essence of all things Fairmont no matter the destination – city center, island retreat, and everything in between. The overriding sensation is being in a place that has meaning and feeling.”

Directed by world-renowned director Nathalie Canguilhem, the campaign showcases five iconic locations: Montreux, Switzerland / Fairmont Le Montreux Palace; New York City / The Plaza, A Fairmont Managed Hotel; Alberta, Canada / Fairmont Banff Springs; British Columbia, Canada / Fairmont Hotel Vancouver; and the breathtaking landscapes of South Africa. A transformative voyage takes hold through pristine nature and grand elements – connecting places of historic beauty with modern sensibilities and the dreams of a new generation of travelers.

Academy Award winning actress and UNICEF Goodwill Ambassador Susan Sarandon stars in the role of global brand ambassador. With a remarkable film career and reputation of being authentic, caring and promoting positive change, she was a natural choice for Fairmont, having a shared  spirit of adventure, timeless sophistication, empowering purpose, and a passion for thinking globally and acting locally.  Fairmont also shares Ms. Sarandon’s commitment to environmental concerns, and her passion for exploration. Symbolically, she opens and closes the campaign, serving as a guide through the entire transformative journey.

Jean-Guilhem Lamberti, Chief Creative Officer, Accor, added: “Brands are never as strong as when they are true to their original vision. With this campaign, I wanted to go back to the brand’s origins and to express the awe and enchantment that one feels when entering a Fairmont hotel. The grandest of feelings call for the grandest of expressions: the mighty architecture of the hotels meets the most pristine awe-inspiring nature in an effortlessly artistic parallel. Nature invades the spaces of the hotels and vice-versa in a symbiotic and visually arresting style. It all seems very relevant in today’s environment as everyone is longing to set free on majestic journeys and rediscover the beauty and grandeur of our world.”

Fairmont’s pioneering approach to hospitality extends to its mission for preserving and protecting the landscapes it calls home. A remarkable 30 years ago, Fairmont became the first luxury hotel brand with a comprehensive and global sustainability program, that now forms part of Accor’s Planet 21 program.  Safeguarding the planet’s star-studded skies, snow-capped mountains, treasured forests, and beyond blue waters so they remain spectacular is of the utmost importance to the entire Experience The Grandest of Feelings platform.

The campaign will debut in markets worldwide aimed at inspiring that collective curiosity that drives guests to journey in search of new surroundings: a new restaurant that transports them across the globe in one bite, a scenic view shared amongst strangers, an unexpected cultural experience that still proves how much we all have in common. Travel brings us all together and only Fairmont truly evokes those feelings of grandeur set amongst a determined purpose to preserving nature.

In the coming months, Fairmont Hotels & Resorts locations across the globe will also debut “The Grandest of Escapes Exclusively by Fairmont” offers that will bring to life the imagery and ethos of the creative through a series of exciting once-in-a-lifetime experiences.

About Fairmont
Fairmont Hotels & Resorts is where the intimate equally coexists with the infinite – an unrivaled portfolio of more than 80 extraordinary hotels where grand moments of life, heartfelt pleasures and personal milestones are celebrated and remembered long after any visit. Since 1907, Fairmont has created magnificent, meaningful and unforgettable hotels, rich with character and deeply connected to the history, culture and community of its destinations – places such as The Plaza in New York City, The Savoy in London, Fairmont San Francisco, Fairmont Banff Springs in Canada, Fairmont Peace Hotel in Shanghai, and Fairmont The Palm in Dubai. Famous for its engaging service, awe-inspiring public spaces, locally inspired cuisine, and iconic bars and lounges, Fairmont also takes great pride in its pioneering approach to hospitality and leadership in sustainability and responsible tourism practices. Fairmont is part of Accor, a world leading hospitality group consisting of more than 5,100 properties and 10,000 food and beverage venues throughout 110 countries.

fairmont.com  all.accor.com group.accor.com

Max Buccini, Senior Vice President, H&S PR, mbuccini@hs-pr.comPatricia Courtney, Global Brand Communications, Accor, patricia.courtney@accor.com

 

EdgeVerve’s AssistEdge 19.0 to Empower Human-Digital workforce to Build High-Performance Enterprise

Enterprises to experience connected automation that will connect people, processes & data to unlock enterprise-wide benefits

BENGALURU, India, Sept. 14, 2021 /PRNewswire/ — EdgeVerve Systems, a wholly-owned subsidiary of Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, recently unveiled the latest version of its Automation platform AssistEdge 19.0. This new version of the platform is designed to support and scale large process automation programs for global enterprises. Enterprises can now get empowered with granular process visibility and sophisticated orchestration capabilities to seamlessly integrate bots, human experts, and AI technologies to meet key business objectives.

EdgeVerve Logo

Intelligent Automation is fast becoming a catalyst in architecting the future of enterprise. However, the real benefits accrue only when Intelligent Automation is adopted at scale. As enterprises move along the automation maturity curve, many consistent barriers arising from disconnected automation implementation, continue to hold them back from adopting automation at scale. To derive sustainable value, organizations need to build capability to deliver personalized customer journeys on a foundation of hyper-efficient execution. This would reshape the enterprise to tap human expertise for empathy and innovation, while leveraging bots for productivity and quality.

AssistEdge 19.0 provides enterprises the opportunity to connect:

  • People – Wider connection of people into automation journey through low code platforms for citizen developers and enterprise personal automation assistants.
  • Process – Stronger connection of processes into automation journey with end-to-end process orchestration through workflows and auto-automation.
  • Data – Deeper connection of data into automation journey through contextual data discovery, intelligent document processing and advanced insights.

“The next frontier in digital transformation will be achieved by integrating business processes across multiple business units. AssistEdge 19.0, a platform best suited for large enterprises, will champion this shift by connecting people, process, data across business units, with insight led decision-making,” said Sateesh Seetharamiah, Chief Business Officer and Global Head, Edge Products, EdgeVerve Systems Ltd.

About AssistEdge

AssistEdge offers a cohesive automation platform that enables enterprises to scale in their automation journey. It offers enterprises with a comprehensive suite of products enabling them to drive initiatives around process discovery, intelligent automation and digital workforce orchestration. AssistEdge has helped enterprises unlock value in the form of reduced service time, faster sales cycles, better resource allocation, accelerated revenue recognition and improved efficiency among others.

https://www.edgeverve.com/assistedge/

About EdgeVerve

EdgeVerve Systems Limited, a wholly owned subsidiary of Infosys, is a global leader in AI and Automation, assisting clients thrive in their digital transformation journey. Our mission is to create a world where our technology augments human intelligence and creates possibilities for enterprises to thrive. Our comprehensive product portfolio across AI (Infosys Nia), Automation (AssistEdge)  and Supply Chain (TradeEdge), helps businesses develop deeper connections with stakeholders, power continuous innovation and accelerate growth in the digital world. Today EdgeVerve’s products are used by global corporations across financial services, insurance, retail, consumer & packaged goods, life sciences, manufacturing telecom and utilities. Visit us to know how enterprises across the world are thriving with the help of our technology.

https://www.edgeverve.com/

About Infosys

Infosys is a global leader in next-generation digital services and consulting. We enable clients in more than 50 countries to navigate their digital transformation. With over four decades of experience in managing the systems and workings of global enterprises, we expertly steer our clients through their digital journey. We do it by enabling the enterprise with an AI-powered core that helps prioritize the execution of change. We also empower the business with agile digital at scale to deliver unprecedented levels of performance and customer delight. Our always-on learning agenda drives their continuous improvement through building and transferring digital skills, expertise, and ideas from our innovation ecosystem.

Visit www.infosys.com to see how Infosys (NSE, BSE, NYSE: INFY) can help your enterprise navigate your next.

Safe Harbor

Certain statements in this release concerning our future growth prospects, financial expectations and plans for navigating the COVID-19 impact on our employees, clients and stakeholders are forward-looking statements intended to qualify for the ‘safe harbor’ under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding COVID-19 and the effects of government and other measures seeking to contain its spread, risks related to an economic downturn or recession in India, the United States and other countries around the world, changes in political, business, and economic conditions, fluctuations in earnings, fluctuations in foreign exchange rates, our ability to manage growth, intense competition in IT services including those factors which may affect our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, industry segment concentration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks or system failures, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which Infosys has made strategic investments, withdrawal or expiration of governmental fiscal incentives, political instability and regional conflicts, legal restrictions on raising capital or acquiring companies outside India, unauthorized use of our intellectual property and general economic conditions affecting our industry and the outcome of pending litigation and government investigation. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2021. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in the Company’s filings with the Securities and Exchange Commission and our reports to shareholders. The Company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Company unless it is required by law.

For more information contact PR_Global@Infosys.com

Logo: https://mma.prnewswire.com/media/847965/EdgeVerve_Infosys_Logo.jpg

 

Dante Labs Announces Expansion of its Finance Team with the Appointment of Andre Nel as Chief Financial Officer, Dalila Rahmani as Chief Accounting Officer, Laura D’Angelo as VP Investor Relations and Omar Elbakshish as Senior Director

CAMBRIDGE, United Kingdom, Sept. 14, 2021 (GLOBE NEWSWIRE) — Dante Labs, a global leader in genomics and precision medicine, today announced the appointments of Andre Nel, Dalila Rahmani, Laura D’Angelo and Omar Elbakshish to the company’s management team, expanding its global leadership to help scale the growing business.

“We are thrilled to welcome Andre, Dalila, Laura and Omar to the expanding leadership team here at Dante,” said Andrea Riposati, CEO of Dante Labs. “As we work to deliver a more human approach to healthcare, it is our shared vision of the future and growing importance genomics is playing in healthcare that will help to meet the unmet needs of our customers from whole genome sequencing to drug discovery and development to COVID testing.”

These leaders will join Dante’s finance team to help scale the business as we work to deliver a global brand of tests and services resulting in better outcomes for people around the world.

Leading the team, Andre Nel joins Dante Labs as Chief Financial Officer. Andre brings more than 20 years of experience providing high-value strategic and operational financial support for global multibillion-dollar organizations such as Pfizer and Illumina. Most recently, Andre was the Vice President of Finance at Illumina (NASDAQ: ILMN) in San Diego.

Dalila joins Dante Labs as the Chief Accounting Officer. Dalila previously worked with Andre at Illumina as the head of Controllership and Shared Services for the EMEA region. Dalila has most recently led the Illumina Commercial Finance team, specializing in financial forecasting, budgeting, business partnering and management. Prior to joining Illumina she started her career as an auditor with Ernst & Young. Dalila has a demonstrated history working in the biotechnology industry and a master’s degree focused on Accounting and Finance. Her work in the industry will benefit us greatly in our more personalized approach to medicine and healthcare.

Laura D’Angelo joins Dante Labs as Vice President of Investor Relations. Most recently, Laura was the Head of Investor Relations at Invitae (NYSE: NVTA), specializing in external communication targeting analysts, investors and financial media as well as clinician and patient customers. With a career rooted in communications, Laura brings a unique perspective to Dante’s finance team as we turn sequencing data into life-saving answers for the people we serve.

Omar Elbakshish joins Dante Labs as Senior Director of Business Finance. Skilled in financial modeling, forecasting and business partnering, Omar also joins Dante from Illumina. With a demonstrated history working in finance roles in the biotechnology industry throughout his career, Omar will help Dante to deploy genomic applications that have real impact on people’s lives.

“I’m so pleased to be leading this passionate and talented finance team here at Dante Labs to help accelerate genomics on a global scale to improve healthcare outcomes,” said Andre Nel, Chief Financial Officer of Dante Labs. “Having worked previously with Dalila and Omar and now collaborating with Laura, I’m confident we have the right team of professionals to achieve our mission and demonstrate how essential genomics is to a holistic and human approach to healthcare around the world.”

About Dante Labs
Dante Labs is a global genomic data company building and commercializing a new class of transformative health and longevity applications based on whole genome sequencing and AI. Our assets include one of the largest private genome databases with research consent, a proprietary software platform designed to unleash the power of genomic data at scale and proprietary processes which enable an industrial approach to genomic sequencing.

Headquartered in Cambridge, United Kingdom, with a research laboratory in Wolverhampton, Dante Labs supported the UK Government’s urgent requirement to scale-up a high-capacity, highly automated testing solution for Covid-19, including infected patients as well as those with antibodies. Dante Labs was able to deliver by leveraging existing technology that had been developed for whole genome sequencing.

Contact
Giorgio Lodi
media@dantelabs.com
+39 0862 191 0671
www.dantelabs.com

Madison Realty Capital Originates $450 Million Construction Loan for 1,098-unit Mixed Use Development in Downtown Brooklyn

NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) — Madison Realty Capital, a vertically integrated real estate private equity firm focused on debt and equity investment strategies, today announced it has provided a $450 million loan to The Rabsky Group, one of the largest residential and commercial developers in Brooklyn and Queens, to complete development of a 1,098-unit, 35-story multifamily and retail mixed-use property at 625-635 Fulton Street at the intersection of Flatbush Avenue in Downtown Brooklyn, New York.

Josh Zegen, Managing Principal and Co-Founder of Madison Realty Capital, said, “This transaction represents Madison Realty Capital’s ability to deliver speed, certainty, and execution to top-tier borrowers in highly attractive submarkets. Accordingly, we are pleased to provide The Rabsky Group, a highly sophisticated and experienced developer with significant holdings throughout the New York metropolitan area, with a large and flexible financing solution. Downtown Brooklyn is an ever-expanding neighborhood and new multifamily housing options, particularly of this caliber, will be quickly absorbed. We are glad to support a property under development that will offer significant affordable housing options and look forward to expanding our relationship with The Rabsky Group for additional projects that positively impact New York City.”

Brooklyn is New York City’s most populous borough and is home to one of the most diverse economies in the country. Proximity to major employment hubs and education centers have made Downtown Brooklyn one of New York’s fastest growing residential markets. Moreover, Downtown Brooklyn has also become a technology and innovation hub and is home to 25 percent of New York City-based tech firms. The property is located within the Brooklyn Tech Triangle, an area comprised of Downtown Brooklyn, DUMBO, and the Brooklyn Navy Yard that has emerged as New York City’s largest cluster of tech activity outside of Manhattan and is within two blocks of ten different subway lines.

Designed with two interconnected residential towers atop a five-story podium, the property will offer 590,096 rentable residential square feet across 342 studios, 492 one-bedroom and 264 two-bedroom units and 30% of the units will be affordable through the Affordable New York program. A portion of the affordable units will be part of the Inclusionary Housing Program for lower income tenants. Residents will enjoy top-of-the-line amenities including a fitness facility, spa, recreation areas, in-unit washers and dryers, lounges, and a rooftop outdoor pool with views of Manhattan and Brooklyn. In addition to best-in-class residential units the property will have 25,988 rentable square feet of retail space along Fulton Street, 250 parking spaces and 150 storage units.

The Rabsky Group is led by Simon Dushinsky, Yadler Rabinowitz, and Joel Gluck, who also contributed significant cash equity for the construction.

Henry Bodek of Galaxy Capital served as broker for the transaction.

About Madison Realty Capital 

Madison Realty Capital is a vertically integrated real estate private equity firm that manages approximately $6 billion in total assets on behalf of an institutional global investor base. Since 2004, Madison Realty Capital has completed more than $15 billion in transactions in the U.S. providing reputable borrowers with flexible and highly customized financing solutions, strong underwriting capabilities, and certainty of execution. Headquartered in New York City, with offices in Los Angeles and Miami, the firm has over 60 employees across all real estate investment, development, and property management disciplines. Madison Realty Capital has been frequently named to the Commercial Observer’s prestigious “Power 100” list of New York City real estate players and is consistently cited as a top construction lender, among other industry recognitions. To learn more, follow us on LinkedIn and visit www.madisonrealtycapital.com.

Nathaniel Garnick/Grace Cartwright
Gasthalter & Co.
(212) 257-4170
madisonrealty@gasthalter.com

Tech Companies Datamaran and Intelex Team Up to Provide a Full-Suite ESG Software Solution

The exclusive relationship allows Intelex customers to manage the full life cycle of their ESG strategy, including Materiality Analysis and Risk Identification.

Toronto, Canada, Sept. 14, 2021 (GLOBE NEWSWIRE) — Intelex Technologies, ULC, a leading global provider of cloud-based Environmental, Health, Safety and Quality (EHSQ) management software, today announced it has entered an exclusive reseller partnership with Datamaran®, the only automated solution available to achieve a data-driven business process for external risk and materiality analysis. Working together, Datamaran and Intelex are helping customers accelerate their strategic and operational goals with a single source, fully automated and data-driven process.

Justin McElhattan, President and CEO of Intelex said, “We are very excited to partner with Datamaran to provide our customers with Datamaran’s industry-leading risk monitoring and materiality intelligence. Alongside Datamaran, we are able to offer our customers a superb experience that allows them to accelerate their ESG transformation by applying best-in-class data science and analytics.”

With this exclusive reseller partnership, Intelex customers will use Datamaran to identify, monitor and gain insights into emerging business and social issues with a dynamic risk and materiality process. The partnership provides organizations with unique risk monitoring and materiality capabilities, including Datamaran for Executives, a comprehensive solution to ensure that the most complete set of material risks are accurately captured for risk management, transparently communicated in annual disclosures and consistently reported up to the board of directors.

Mirroring Intelex’s own approach to providing scalable solutions that match customer ESG requirements, the Datamaran partnership offers customers the flexibility they need to achieve their strategic objectives. With Intelex and Datamaran together, organizations can seamlessly manage and monitor their ESG initiatives, reporting and strategy.

Companies worldwide use Datamaran’s evidence-based approach to inform their materiality, risk management, board oversight and reporting processes. This approach allows them to stay ahead of the curve, in front of the competition and at the top of their game. For an actual use case, you don’t have to look farther than Intelex parent company Fortive.

Pete Underwood, SVP and General Counsel of Fortive explains: “Datamaran continually anticipates and meets our needs, as our ESG and risk management processes evolve and mature. The platform enables a clear view of business-critical issues across the ever-changing landscape.”

With Datamaran and Intelex, senior management communicate timely and relevant information to the board of directors, move materiality from an operational exercise to a strategic process and monitor emerging trends. Using AI, Datamaran’s patented technology identifies and monitors over 400 external risk factors—including ESG, innovation and technology and geopolitical issues—on an ongoing basis by scanning the regulatory, media and corporate disclosure environments. It is the only software analytics platform available to improve risk management, annual reporting and board oversight of external risks and opportunities.

“For the past seven years, blue-chip companies have chosen Datamaran to seriously improve the way in which they go about ESG,” said Marjella Lecourt-Alma, CEO and co-founder of Datamaran. “With Intelex, we’re excited to reach an even larger group of companies. As a software provider with deep expertise in EHS, Intelex understands that ESG is now dominating the corporate market. Our full-suite ESG software solution enables companies to quickly move sustainability from project to process.”

About Datamaran: Datamaran is the only software analytics platform in the world that identifies and monitors external risks, including ESG. Trusted by blue-chip companies and top tier partners, it brings a data-driven business process for external risk and materiality analysis. In house—at any time. Datamaran’s patented technology offers real-time analytics on strategic, regulatory and reputational risks, specific to your business and value chain.

About Intelex Technologies, ULC: Intelex is a global leader in environmental, health, safety and quality (EHSQ) management software. Since 1992, Intelex employees across the globe have been committed to innovating and enabling organizations to send their employees home safely every day, leaving behind a more sustainable world to the generations that follow, and manage quality so that only the safest and highest quality products make it to market.

Intelex’s scalable, web-based platform and applications have helped clients across all industries improve business performance, mitigate organization-wide risk, and ensure sustained compliance with internationally accepted standards (e.g. ISO 9001, ISO 14001, ISO 45001) and OSHAS 18001) and regulatory requirements. Almost 1,400 customers in 195 countries trust Intelex to power their EHSQ initiatives.

Headquartered in Toronto with regional offices and employees around the world, Intelex became an Industrial Scientific company in 2019. In 2020, Intelex acquired ehsAI, provider of a SaaS-based next-wave compliance automation solution that leverages artificial intelligence and machine learning algorithms. For more information about Intelex, visit www.intelex.com.

Sandy Smith
Intelex Technologies, ULC
216-375-0484
sandy.smith@intelex.com

Anaqua Delivers Enhanced IP Management to Bausch Health

Anaqua’s AQX platform to provide patent and trademark management with integrated IP analytics

BOSTON, Sept. 14, 2021 (GLOBE NEWSWIRE) — Anaqua, the leading innovation and intellectual property management technology provider, today announced that Bausch Health Companies Inc. has selected Anaqua’s AQX platform to deliver enhanced IP management across the health care products company’s global operations.

Bausch Health will be using Anaqua’s AQX as their primary IP management system – both for patent and trademark management – replacing their previous IP services provider. Bausch Health will take advantage of Anaqua’s broad range of IP offerings including AcclaimIP for patent analytics, Anaqua Services for patent annuities and trademark renewals, as well as AQX modules for IP contract and financial management.

Commented Bob Romeo, CEO of Anaqua: “Bausch Health is an innovative health care company delivering on its commitment to help people around the world. We are proud to be working with them and to better serve their valuable IP assets through Anaqua’s enhanced innovation and IP management solutions.”

About Anaqua
Anaqua, Inc. is a premium provider of integrated intellectual property (IP) management technology solutions and services. Anaqua’s AQX platform combines best practice workflows with big data analytics and tech-enabled services to create an intelligent environment designed to inform IP strategy, enable IP decision-making, and streamline IP operations. Today, nearly half of the top 100 U.S. patent filers and global brands, as well as a growing number of law firms worldwide use Anaqua’s solutions. Over one million IP executives, attorneys, paralegals, administrators, and innovators use the platform for their IP management needs. The company’s global operations are headquartered in Boston, with offices across the U.S., Europe, and Asia. For additional information, please visit anaqua.com, or on LinkedIn.

Company Contact:
Amanda Hollis
Associate Director, Communications
Anaqua
617-375-2626
ahollis@Anaqua.com

Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse

INSIDE INFORMATION
REGULATED INFORMATION

Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse

Mont-Saint-Guibert (Belgium), September 14, 2021, 8:00 am CET / 2:00 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the U.S. Food and Drug Administration (FDA) has granted the Genio® bilateral hypoglossal nerve stimulation system Breakthrough Device Designation for the treatment of adult patients with moderate to severe OSA and Complete Concentric Collapse (CCC) of the soft palate.

The FDA’s Breakthrough Designation Program was created to help patients and healthcare providers receive faster access to innovative technologies that hold the potential to provide more effective treatment of irreversibly debilitating diseases or conditions. According to the FDA, OSA is an irreversibly debilitating human disease for patients with sleep apnea. Under the Program, the FDA will provide the Genio® system with priority review and interaction with FDA’s experts throughout the premarket review phase until the product is commercialized in the US.

“We are pleased to have received Breakthrough Device Designation for our proprietary Genio® system for OSA patients with CCC, recognizing that Obstructive Sleep Apnea is an irreversibly debilitating condition.” said Olivier Taelman, CEO of Nyxoah. “This Breakthrough Designation accelerates our market authorization process in the US and expands our total addressable market to include CCC patients currently contraindicated for hypoglossal nerve stimulation.”

The Breakthrough Designation is supported by data from the Company’s BETTER SLEEP trial, aimed at addressing the long-term safety and performance of the Genio® system in adult OSA patients with and without CCC.

About BETTER SLEEP Trial
BilatEral Hypoglossal Nerve StimulaTion for TreatmEnt of ObstRuctive SLEEP Apnoea, or BETTER SLEEP, is a multicenter, prospective, open-label, two-group clinical trial, designed to assess the safety and performance of the Genio® system for the treatment of OSA in adult patients with and without CCC. Top-line BETTER SLEEP results showed primary safety and performance endpoints were met, with statistically significant mean reduction in the AHI score in full patient population including CCC patients. Nyxoah will submit full BETTER SLEEP study data to a medical journal for publication and announce results following further analyses.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah is seeking for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and US commercialization approval.

Contacts:
Nyxoah
Fabian Suarez, Chief Financial Officer
corporate@nyxoah.com
+32 10 22 24 55

Gilmartin Group
Vivian Cervantes
IR@nyxoah.com

Attachment

Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference

Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference

Mont-Saint-Guibert (Belgium), September 13, 2021, 10:30 pm CET / 4:30 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Olivier Taelman, Chief Executive Officer, will participate at the Cantor 2021 Global Healthcare Conference on Tuesday, September 28, 2021, with a virtual presentation at 4:00 pm CET/10:00 am ET.

A live webcast and replay of this event will be available on the Company’s investors relations website at https://investors.nyxoah.com/

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah is seeking for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and US commercialization approval.

Contacts:
Nyxoah
Fabian Suarez, Chief Financial Officer
fabian.suarez@nyxoah.com
+32 10 22 24 55

Gilmartin Group
Vivian Cervantes
vivian.cervantes@gilmartinir.com

Attachment

Gates Foundation’s Annual Goalkeepers Report Finds Stark Disparities in COVID-19 Impacts

New data reveals world stepped up to prevent worst-case scenarios from happening; spotlights need for long-term investments to ensure an equitable recovery and continued progress toward the Global Goals

SEATTLE, Sept. 14, 2021 /PRNewswire/ — The Bill & Melinda Gates Foundation today launched its fifth annual Goalkeepers Report, featuring an updated global dataset illustrating the pandemic’s adverse impact on progress toward the United Nations Sustainable Development Goals (Global Goals).

This year’s report, co-authored by Bill Gates and Melinda French Gates, co-chairs of the Bill & Melinda Gates Foundation, shows that disparities caused by COVID-19 remain stark, and those who have been hardest hit by the pandemic will be the slowest to recover. Because of COVID-19, an additional 31 million people were pushed into extreme poverty in 2020 compared to 2019. And while 90% of advanced economies will regain pre-pandemic per capita income levels by next year, only a third of low- and middle-income economies are expected to do so.

Fortunately, amidst this devastation, the world stepped up to avert some of the worst-case scenarios. In last year’s Goalkeepers Report, the Institute for Health Metrics and Evaluation (IHME) predicted a drop of 14 percentage points in global vaccine coverage—effectively erasing 25 years of progress in 25 weeks. New analysis from IHME demonstrates that the decline, while still unacceptable, was only half of what was anticipated.

In the report, the co-chairs highlight the “breathtaking innovation” that was only possible because of global collaboration, commitment, and investments over decades. They acknowledge that averting the worst-case scenarios is commendable, yet they note it’s not enough. To ensure a truly equitable recovery from the pandemic, they call for long-term investments in health and economies—like the ones that led to the rapid development of the COVID-19 vaccine—to propel recovery efforts and get the world back on track to meet the Global Goals.

“[The past year] has reinforced our belief that progress is possible but not inevitable,” write the co-chairs. “If we can expand upon the best of what we’ve seen these past 18 months, we can finally put the pandemic behind us and once again accelerate progress in addressing fundamental issues like health, hunger, and climate change.”

The report highlights the disproportionate economic impact that the pandemic has had on women globally. In high- and low-income countries alike, women have been harder hit than men by the global recession that was triggered by the pandemic.

“Women face structural barriers in every corner of the world, leaving them more vulnerable to the impacts of the pandemic,” said Melinda French Gates. “By investing in women now and addressing these inequities, governments can spur a more equitable recovery while strengthening their economies against future crises. It’s not just the right thing to do—but smart policy that will benefit everyone.”

The report also illustrates how the so-called “miracle” of COVID-19 vaccines was the result of decades of investment, policies, and partnerships that established the infrastructure, talent, and ecosystems necessary to deploy them quickly. However, the systems that allowed for the unprecedented development and deployment of the COVID-19 vaccine exist primarily in wealthy countries, and as a result, the world has not benefited equally.

“The lack of equitable access to COVID-19 vaccines is a public health tragedy,” said Bill Gates. “We face the very real risk that in the future, wealthy countries and communities will begin treating COVID-19 as yet another disease of poverty. We can’t put the pandemic behind us until everyone, regardless of where they live, has access to vaccines.”

More than 80% of all COVID-19 vaccines have been administered in high- and upper-middle-income countries to date, with some securing two to three times the number needed so they can cover boosters; less than 1% of doses have been administered in low-income countries. Further, COVID-19 vaccine access has been strongly correlated with the locations where there is vaccine R&D and manufacturing capability. Though Africa is home to 17% of the world’s population, for example, it has less than 1% of the world’s vaccine manufacturing capabilities.

Ultimately, the report calls for the world to invest in R&D, infrastructure, and innovation in places closer to the people who stand to benefit.

“We must invest in local partners to strengthen the capacity of researchers and manufacturers in lower-income countries to create the vaccines and medicines they need,” said Gates Foundation CEO Mark Suzman. “The only way we will solve our greatest health challenges is by drawing on the innovation and talent of people all over the world.”

About the Bill & Melinda Gates Foundation

Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Mark Suzman, under the direction of Bill Gates and Melinda French Gates.

About Goalkeepers

Goalkeepers is the foundation’s campaign to accelerate progress towards the Sustainable Development Goals (Global Goals). By sharing stories and data behind the Global Goals through an annual report, we hope to inspire a new generation of leaders—Goalkeepers who raise awareness of progress, hold their leaders accountable, and drive action to achieve the Global Goals.

About the Global Goals

On September 25, 2015, at the United Nations headquarters in New York, 193 world leaders committed to the 17 Sustainable Development Goals (Global Goals). These are a series of ambitious objectives and targets to achieve three extraordinary things by 2030: end poverty, fight inequality and injustice, and fix climate change.

Media Contact: media@gatesfoundation.org                                   
Report Link: https://www.gatesfoundation.org/goalkeepers/report/2021-report/
Report Visual Assets:
http://gatesfoundation.isebox.net/goalkeepers/goalkeepers-report-2021